Harri Marttila

1.9k total citations
31 papers, 866 citations indexed

About

Harri Marttila is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Harri Marttila has authored 31 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Infectious Diseases, 17 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Harri Marttila's work include Mycobacterium research and diagnosis (15 papers), Tuberculosis Research and Epidemiology (14 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Harri Marttila is often cited by papers focused on Mycobacterium research and diagnosis (15 papers), Tuberculosis Research and Epidemiology (14 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). Harri Marttila collaborates with scholars based in Finland, United States and France. Harri Marttila's co-authors include Hanna Soini, Matti K. Viljanen, Merja Marjamäki, Johanna Mäkinen, Boris Vyshnevskiy, Erkki Eerola, Pentti Huovinen, Jarmo Oksi, Esa Rintala and Thijs Feuth and has published in prestigious journals such as PLoS ONE, Scientific Reports and Journal of Clinical Microbiology.

In The Last Decade

Harri Marttila

28 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harri Marttila Finland	17	698	571	242	136	72	31	866
Véronique Joly France	15	444 0.6×	376 0.7×	116 0.5×	77 0.6×	44 0.6×	43	794
Mallika Lavania India	18	786 1.1×	618 1.1×	353 1.5×	58 0.4×	30 0.4×	73	866
Maria Bruna Pasticci Italy	15	599 0.9×	618 1.1×	217 0.9×	80 0.6×	80 1.1×	59	936
Katrin Kösters Germany	10	257 0.4×	306 0.5×	110 0.5×	81 0.6×	54 0.8×	16	542
Kabanda Taseera Uganda	16	966 1.4×	1.1k 1.9×	64 0.3×	36 0.3×	20 0.3×	36	1.2k
Eddie Louie United States	12	467 0.7×	621 1.1×	120 0.5×	57 0.4×	6 0.1×	25	908
Tirdad T. Zangeneh United States	15	283 0.4×	313 0.5×	35 0.1×	48 0.4×	62 0.9×	56	551
Lisa Brumble United States	16	470 0.7×	521 0.9×	147 0.6×	38 0.3×	6 0.1×	55	791
Michael Saccente United States	11	844 1.2×	874 1.5×	141 0.6×	43 0.3×	42 0.6×	26	1.1k
Yaşar Bayındır Türkiye	13	95 0.1×	158 0.3×	76 0.3×	60 0.4×	36 0.5×	71	478

Countries citing papers authored by Harri Marttila

Since Specialization

Citations

This map shows the geographic impact of Harri Marttila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harri Marttila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harri Marttila more than expected).

Fields of papers citing papers by Harri Marttila

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harri Marttila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harri Marttila. The network helps show where Harri Marttila may publish in the future.

Co-authorship network of co-authors of Harri Marttila

This figure shows the co-authorship network connecting the top 25 collaborators of Harri Marttila. A scholar is included among the top collaborators of Harri Marttila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harri Marttila. Harri Marttila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vuopio, Jaana, et al.. (2025). Decolonization of methicillin-resistant Staphylococcus aureus – effectiveness of decolonization treatment. Antimicrobial Stewardship & Healthcare Epidemiology. 5(1). e234–e234.

Czarnecki, Jakub, Mari Kanerva, Irmeli Lindström, et al.. (2025). Third Streptococcus pneumoniae disease outbreak involving serotype 4–ST801 in a shipyard, Finland, May to June 2025. Eurosurveillance. 30(41).

Kanerva, Mari, et al.. (2025). Economic impact and disease burden of COVID-19 in a tertiary care hospital: A three-year analysis. PLoS ONE. 20(5). e0323200–e0323200.

Gröndahl‐Yli‐Hannuksela, Kirsi, Kaisu Rantakokko‐Jalava, Mari Kanerva, et al.. (2024). Increasing trend of antimicrobial resistance among methicillin-resistant Staphylococcus aureus strains in Southwest Finland, 2007–2016: An analysis of shifting strain dynamics and emerging risk factors. Journal of Global Antimicrobial Resistance. 40. 47–52. 2 indexed citations

Gröndahl‐Yli‐Hannuksela, Kirsi, Kaisu Rantakokko‐Jalava, Esa Rintala, et al.. (2022). Whole genome sequencing reveals new links between spa t172/CC59 methicillin-resistant Staphylococcus aureus cases in low-endemicity region of Southwest Finland, 2007‒2016. Scientific Reports. 12(1). 21326–21326. 2 indexed citations

Broman, Niklas, Thijs Feuth, Tytti Vuorinen, et al.. (2022). Early administration of tocilizumab in hospitalized COVID-19 patients with elevated inflammatory markers; COVIDSTORM—a prospective, randomized, single-centre, open-label study. Clinical Microbiology and Infection. 28(6). 844–851. 23 indexed citations

Broman, Niklas, Thijs Feuth, M. Valtonen, et al.. (2020). IL-6 and other biomarkers as predictors of severity in COVID-19. Annals of Medicine. 53(1). 410–412. 74 indexed citations

Rintala, Esa, Kari Auranen, Kaisu Rantakokko‐Jalava, et al.. (2020). Changing epidemiology of methicillin-resistant Staphylococcus aureus in a low endemicity area—new challenges for MRSA control. European Journal of Clinical Microbiology & Infectious Diseases. 39(12). 2299–2307. 34 indexed citations

Gröndahl‐Yli‐Hannuksela, Kirsi, et al.. (2020). Performance of the Check-Direct ESBL Screen for BD MAXTM for detection of asymptomatic faecal carriage of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae. Journal of Global Antimicrobial Resistance. 22. 408–413. 6 indexed citations

10.

Munukka, Eveliina, Suvi Sippola, Sirpa Jalkanen, et al.. (2019). Prospective multicentre cohort trial on acute appendicitis and microbiota, aetiology and effects of antimicrobial treatment: study protocol for the MAPPAC (Microbiology APPendicitis ACuta) trial. BMJ Open. 9(9). e031137–e031137. 21 indexed citations

11.

Haijanen, Jussi, Juha Grönroos, Tero Rautio, et al.. (2018). Optimising the antibiotic treatment of uncomplicated acute appendicitis: a protocol for a multicentre randomised clinical trial (APPAC II trial). BMC Surgery. 18(1). 117–117. 32 indexed citations

12.

Mäkinen, Johanna, Merja Marjamäki, Harri Marttila, et al.. (2011). Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: a population-based study. European Journal of Clinical Microbiology & Infectious Diseases. 30(9). 1119–1126. 25 indexed citations

13.

Marttila, Harri, Johanna Mäkinen, Merja Marjamäki, & Hanna Soini. (2008). Prospective evaluation of pyrosequencing for the rapid detection of isoniazid and rifampin resistance in clinical Mycobacterium tuberculosis isolates. European Journal of Clinical Microbiology & Infectious Diseases. 28(1). 33–38. 29 indexed citations

14.

Mattila, Eero, Veli-Jukka Anttila, Markku Broas, et al.. (2008). A randomized, double-blind study comparing Clostridium difficile immune whey and metronidazole for recurrent Clostridium difficile-associated diarrhoea: Efficacy and safety data of a prematurely interrupted trial. Scandinavian Journal of Infectious Diseases. 40(9). 702–708. 59 indexed citations

15.

Mäkinen, Johanna, Merja Marjamäki, Harri Marttila, & Hanna Soini. (2006). Evaluation of a novel strip test, GenoType Mycobacterium CM/AS, for species identification of mycobacterial cultures. Clinical Microbiology and Infection. 12(5). 481–483. 49 indexed citations

16.

Jalava, Jari & Harri Marttila. (2004). Application of molecular genetic methods in macrolide, lincosamide and streptogramin resistance diagnostics and in detection of drug‐resistant Mycobacterium tuberculosis. Apmis. 112(11-12). 838–855. 9 indexed citations

17.

Marttila, Harri, et al.. (2004). Prospective evaluation of the GenoType Assay for routine identification of mycobacteria. European Journal of Clinical Microbiology & Infectious Diseases. 23(8). 642–5. 38 indexed citations

18.

Marttila, Harri, et al.. (2003). Performance of BACTEC 960 Mycobacteria Growth Indicator Tube in the Susceptibility Testing of Genetically Characterized Mycobacterium tuberculosis Isolates. European Journal of Clinical Microbiology & Infectious Diseases. 22(12). 757–759. 4 indexed citations

19.

Rantakokko‐Jalava, Kaisu, et al.. (2001). LCxMycobacterium tuberculosisassay is valuable with respiratory specimens, but provides little help in the diagnosis of extrapulmonary tuberculosis. Annals of Medicine. 33(1). 55–62. 9 indexed citations

20.

Oksi, Jarmo, Harri Marttila, Hanna Soini, et al.. (2001). Early dissemination of Borrelia burgdorferi without generalized symptoms in patients with erythema migrans^Note. Apmis. 109(9). 581–588. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact